Linagliptin and cardiovascular outcomes in type 2 diabetes after acute coronary syndrome or acute ischemic stroke
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Linagliptin and cardiovascular outcomes in type 2 diabetes after acute coronary syndrome or acute ischemic stroke
Authors
Keywords
Linagliptin, Dipeptidyl peptidase-4 (DPP-4) inhibitor, Type 2 diabetes mellitus, Acute coronary syndrome, Acute ischemic stroke, Cardiovascular outcome
Journal
Cardiovascular Diabetology
Volume 17, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-01-04
DOI
10.1186/s12933-017-0655-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy and Cardiovascular Safety of Linagliptin as an Add-On to Insulin in Type 2 Diabetes: A Pooled Comprehensive Post Hoc Analysis
- (2016) Bernard Zinman et al. Canadian Journal of Diabetes
- Risks of cardiovascular diseases associated with dipeptidyl peptidase-4 inhibitors and other antidiabetic drugs in patients with type 2 diabetes: a nation-wide longitudinal study
- (2016) Huang-Tz Ou et al. Cardiovascular Diabetology
- Dipeptidyl peptidase-4 inhibition with linagliptin prevents western diet-induced vascular abnormalities in female mice
- (2016) Camila Manrique et al. Cardiovascular Diabetology
- DPP-4 Inhibitors and Heart Failure: Some Reassurance, Some Uncertainty
- (2016) Kristian B. Filion et al. DIABETES CARE
- Standards of care for type 2 diabetes in China
- (2016) Jianping Weng et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Safety and efficacy of linagliptin in patients with type 2 diabetes mellitus and coronary artery disease: Analysis of pooled events from 19 clinical trials
- (2016) Michael Lehrke et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Cardiovascular safety of linagliptin in type 2 diabetes: a comprehensive patient-level pooled analysis of prospectively adjudicated cardiovascular events
- (2015) Julio Rosenstock et al. Cardiovascular Diabetology
- Impact of Diabetes Mellitus on Hospitalization for Heart Failure, Cardiovascular Events, and DeathCLINICAL PERSPECTIVE
- (2015) Matthew A. Cavender et al. CIRCULATION
- Validating the diagnosis of acute ischemic stroke in a National Health Insurance claims database
- (2015) Cheng-Yang Hsieh et al. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
- Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial
- (2015) Faiez Zannad et al. LANCET
- Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes
- (2015) Jennifer B. Green et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nationwide Population Science
- (2015) Ann W. Hsing et al. JAMA Internal Medicine
- Heart Failure, Saxagliptin, and Diabetes Mellitus: Observations from the SAVOR-TIMI 53 Randomized Trial
- (2014) Benjamin M. Scirica et al. CIRCULATION
- Safety and Tolerability of Linagliptin in Patients With Type 2 Diabetes: A Comprehensive Pooled Analysis of 22 Placebo-controlled Studies
- (2014) Michael Lehrke et al. CLINICAL THERAPEUTICS
- Efficacy of acarbose in different geographical regions of the world: analysis of a real-life database
- (2014) Jianping Weng et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Linagliptin: An Update of Its Use in Patients with Type 2 Diabetes Mellitus
- (2014) Kate McKeage DRUGS
- Linagliptin for the treatment of type 2 diabetes mellitus: a drug safety evaluation
- (2014) Anthony H Barnett Expert Opinion On Drug Safety
- Validation of Acute Myocardial Infarction Cases in the National Health Insurance Research Database in Taiwan
- (2014) Ching-Lan Cheng et al. JOURNAL OF EPIDEMIOLOGY
- Continuation of statin therapy and a decreased risk of atrial fibrillation/flutter in patients with and without chronic kidney disease
- (2013) Chia-Hsuin Chang et al. ATHEROSCLEROSIS
- Comparison of the Hypoglycemic Effect of Acarbose Monotherapy in Patients With Type 2 Diabetes Mellitus Consuming an Eastern or Western Diet: A Systematic Meta-analysis
- (2013) Qibo Zhu et al. CLINICAL THERAPEUTICS
- Atherosclerotic intracranial arterial stenosis: risk factors, diagnosis, and treatment
- (2013) Christine A Holmstedt et al. LANCET NEUROLOGY
- Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes
- (2013) William B. White et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 Diabetes
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
- (2013) Benjamin M. Scirica et al. NEW ENGLAND JOURNAL OF MEDICINE
- Acarbose: an alternative to metformin for first-line treatment in type 2 diabetes?
- (2013) Ronald CW Ma Lancet Diabetes & Endocrinology
- Cardiovascular safety with linagliptin in patients with type 2 diabetes mellitus: a pre-specified, prospective, and adjudicated meta-analysis of a phase 3 programme
- (2012) Odd Johansen et al. Cardiovascular Diabetology
- The DPP-4 Inhibitor Linagliptin Counteracts Stroke in the Normal and Diabetic Mouse Brain: A Comparison With Glimepiride
- (2012) V. Darsalia et al. DIABETES
- Association Between Nucleoside Analogues and Risk of Hepatitis B Virus–Related Hepatocellular Carcinoma Recurrence Following Liver Resection
- (2012) Chun-Ying Wu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- 2-year efficacy and safety of linagliptin compared with glimepiride in patients with type 2 diabetes inadequately controlled on metformin: a randomised, double-blind, non-inferiority trial
- (2012) Baptist Gallwitz et al. LANCET
- Effect of renal impairment on the pharmacokinetics of the dipeptidyl peptidase-4 inhibitor linagliptin*
- (2011) U. Graefe-Mody et al. DIABETES OBESITY & METABOLISM
- Pharmacology of Dipeptidyl Peptidase-4 Inhibitors
- (2011) Roberta Baetta et al. DRUGS
- Long-Term Effects of Intensive Glucose Lowering on Cardiovascular Outcomes
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies
- (2010) The Emerging Risk Factors Collaboration LANCET
- Validation of the national health insurance research database with ischemic stroke cases in Taiwan
- (2010) Ching-Lan Cheng et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Trends in All-Cause and Cardiovascular Disease Mortality Among Women and Men With and Without Diabetes Mellitus in the Framingham Heart Study, 1950 to 2005
- (2009) Sarah Rosner Preis et al. CIRCULATION
- Linagliptin, a xanthine-based dipeptidyl peptidase-4 inhibitor with an unusual profile for the treatment of type 2 diabetes
- (2009) Carolyn F Deacon et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Paget's Disease of the Mandible
- (2008) Mayank B. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Intensive Glucose Lowering in Type 2 Diabetes
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now